Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Chubb
McKinsey
Baxter
US Army
Daiichi Sankyo
Chinese Patent Office
Dow
Mallinckrodt
Accenture

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,252,721

« Back to Dashboard

Summary for Patent: 4,252,721
Title: Cycloalkyltriazoles and process for obtaining same
Abstract:Compounds of the general formula: ##STR1## in which alk and alk' represent the bivalent radicals; aliphatic alkyl chains; and R and R' represent the alkyl, halogen, hydrogen, alkyloxy, --OH, --CF.sub.3 or --SCH.sub.3 radicals. Said compounds of the formula I are effective and useful as antiglaucomic and antipsychotic agents and also as additive agents in the withdrawal treatment of various addictive conditions. Methods for their preparation are also disclosed.
Inventor(s): Silvestrini; Bruno (Rome, IT), Baiocchi; Leandro (Rome, IT)
Assignee: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. (Rome, IT)
Application Number:06/025,273
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 4,252,721

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,252,721

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Italy22421 A/78Apr 18, 1978

International Patents Family Members for US Patent 4,252,721

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 374477 ➤ Subscribe
Austria 380251 ➤ Subscribe
Austria A292479 ➤ Subscribe
Austria A305982 ➤ Subscribe
Australia 4583279 ➤ Subscribe
Australia 520788 ➤ Subscribe
Bulgaria 40654 ➤ Subscribe
Bulgaria 61367 ➤ Subscribe
Canada 1104567 ➤ Subscribe
Switzerland 639847 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Mallinckrodt
Cipla
Medtronic
AstraZeneca
Dow
Federal Trade Commission
Deloitte
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot